Dow 30 component Johnson & Johnson (JNJ) is a worldwide healthcare focused company that embraces research and science so that it can provide customers with innovative ideas, products, and services.
Johnson & Johnson announced the obtainment of a binding offer from Fortive Corporation for the acquirement of its Advanced Sterilization Products. ASP is a division of the New Jersey corporation Ethicon, Inc. The offer was for an aggregate value of about $2.8B. ASP, a worldwide leader in inventive infection prevention solutions has a net revenue in 2017 of $775 million.
Advanced Sterilization Products helps healthcare facilities prevent hospital-acquired infections, the leading cause of morbidity and mortality. ASP uses capital, consumables, and software for used in Low-Temperature Terminal Sterilization and High-Level Disinfection of reusable surgical instruments.
There is a 120 day period for the acceptance of the offer. If accepted, the purchase would be predicted to close in early 2019 at the latest.
To learn more about Johnson & Johnson (JNJ) and to continue to track its progress visit the Vista Partners Johnson & Johnson Coverage Page.
Vista Partners LLC (”Vista”) is a California Registered Investment Advisor based in San Francisco. Vista delivers timely and relevant insights via the website: www.vistapglobal.com
with daily stories, weekly market updates, monthly macroeconomic newsletters, podcasts, & Vista’s proprietary equity and market research to help you stay informed and stay competitive. Vista’s mission is to invest partner capital while arming investors with a comprehensive global financial perspective across all market sectors. Vista also seeks to provide select issuers with actionable advice regarding fundamental development, corporate governance, and capital market directives.
Stay Informed! Stay Competitive!
Johnson & Johnson Announces Binding Offer from Fortive Corporation to Acquire Advanced Sterilization Products (ASP)
NEW BRUNSWICK, N.J., June 6, 2018 /PRNewswire/ — Johnson & Johnson (NYSE: JNJ) today announced that it has received a binding offer from Fortive Corporation (NYSE: FTV) to acquire its Advanced Sterilization Products (ASP) business, a division of Ethicon, Inc.*, for an aggregate value of approximately $2.8 billion, consisting of $2.7 bi…..